oral semaglutide cardiovascular outcomes soul trial results 2024 2025 nejm soul trial oral semaglutide cardiovascular outcomes 2024 2025 Updates in Medicine Cardio-kidney-metabolic protective effects of semaglutide

The FDA has approved Rybelsus (semaglutide) the first-ever oral diabetes medication proven to protect against heart attacks and strokes, in addition to controlling blood sugar

You have chest pain or feel faint

How to Avoid Sweating After a Shower How to Prevent Sweating After a Post-Workout Shower When to Speak with Your Healthcare Provider About Sweating The Takeaway Lets be honest: One of the greatest joys of a workout is the post-workout shower (which, if you wear a sports bra, comes after the post-workout workout of removing said sports bra)

Long-term Weight Loss with Metformin or Lifestyle Intervention in the Diabetes Prevention Program Outcomes Study

CJC-1295 + Ipamorelin and Sermorelin are the most frequently prescribed options here, because both restore the growth hormone pulses that decline in tandem with estrogen, partially offsetting the compounding hormonal shift that drives vasomotor symptoms